TEZSPIRE
TEZSPIRE is an add-on maintenance treatment for people aged 12 and older with severe asthma. TEZSPIRE is not a rescue medication.
Administration and Dosage:
• Administer by subcutaneous injection.
• Recommended dosage is 210 mg administered once every 4 weeks.
Common Side Effects:
The most common side effects of TEZSPIRE include: Sore throat, joint and back pain. These are not all the possible side effects.
More information:
Please see full Prescribing Information including Patient Information.
Indication:
TEZSPIRE is a thymic stromal lymphopoietin (TSLP) blocker, human monoclonal antibody (IgG2λ), indicated for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma.
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!
Check our Privacy Practice